BridgeBio Pharma: Q3 Earnings Insights


BridgeBio Pharma BBIO reported its Q3 earnings results on Thursday, November 3, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.


BridgeBio Pharma beat estimated earnings by 6.06%, reporting an EPS of $-0.93 versus an estimate of $-0.99.

Revenue was down $2.01 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.18 which was followed by a 12.12% increase in the share price the next day.

Here's a look at BridgeBio Pharma's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.63 -1.11 -0.87 -0.90
EPS Actual -0.81 -1.19 -1.01 -1.06
Revenue Estimate 16.07M 4.69M 21.58M 17.36M
Revenue Actual 73.75M 1.69M 12.89M 2.34M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for BridgeBio Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!